James P. Snyder
Corporate Officer/Principal chez Emory University
Profil
James P.
Snyder is the founder of Altiris Therapeutics, Inc. (founded in 2005) where he held the title of Member-Scientific Advisors in 2012.
He is currently working at Emory University as the Director-Biostructural Research since 2013.
Previously, he worked at Metastatix, Inc. from 2005 to 2009 as the Head-Rational Drug Design.
Dr. Snyder obtained a doctorate degree from Cornell University and an undergraduate degree from Saint Martin's College.
Postes actifs de James P. Snyder
| Sociétés | Poste | Début |
|---|---|---|
| Emory University | Corporate Officer/Principal | - |
Anciens postes connus de James P. Snyder
| Sociétés | Poste | Fin |
|---|---|---|
Metastatix, Inc.
 Metastatix, Inc. Pharmaceuticals: MajorHealth Technology Metastatix, Inc. develops small molecule drugs to treat life-threatening diseases including cancer, HIV infection, and macular degeneration. It has developed a series of novel oral small-molecule CXCR4 inhibitors that have unprecedented biological activity in preclinical models. The company was founded in 2005 and is located in Tucker, GA. | Corporate Officer/Principal | 22/06/2009 |
Altiris Therapeutics, Inc.
 Altiris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Altiris Therapeutics, Inc. develops and commercializes small-molecule drug therapies. The company was founded by Dennis Liotta, Hyunsuk Shim and James P. Snyder in 2005 and is headquartered in Atlanta, GA. | Fondateur | - |
Formation de James P. Snyder
| Cornell University | Doctorate Degree |
| Saint Martin's College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Metastatix, Inc.
Metastatix, Inc. Pharmaceuticals: MajorHealth Technology Metastatix, Inc. develops small molecule drugs to treat life-threatening diseases including cancer, HIV infection, and macular degeneration. It has developed a series of novel oral small-molecule CXCR4 inhibitors that have unprecedented biological activity in preclinical models. The company was founded in 2005 and is located in Tucker, GA. | Health Technology |
Altiris Therapeutics, Inc.
Altiris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Altiris Therapeutics, Inc. develops and commercializes small-molecule drug therapies. The company was founded by Dennis Liotta, Hyunsuk Shim and James P. Snyder in 2005 and is headquartered in Atlanta, GA. | Health Technology |